menu

PARENT PAGES: PHILOSOPHY

Regulatory Approval Proves Benefit?

Regulatory approval proves medical benefit? We disagree. Reimbursed technologies that have been exploited or result in unnecessary care are too numerous to list. We take this one step further and analyze eight questions to help determine medical appropriateness and long-term clinical consequences. The advantage is not only humanitarian. It reduces risk of poor global acceptance or a future disruptive reimbursement decrease. 

READ MORE
Ethical Filter

Our “Ethical Filter” is both a moral and a financial asset Solves a serious or unsolved problem? Cost-effective? Possible new Standard of Care? Potential for inappropriate use? Potential negative consequences? Potential for harm? Would I recommend it for my family? Would I pay for it myself?

READ MORE
Testimonials

TESTIMONIALS

READ MORE
Engaged Diligence

Our unique “Engaged Diligence” process dramatically increases transparency We skip the typical due-diligence show and instead, during our months-long Engaged Diligence we learn about the company and its people, products, and processes: Join boards Craft clinical trials Solve technical problems Draft strategy plans Identify operational issues Find strategic partners

READ MORE
Our Approach Discussion

GREYBIRD WAS FOUNDED AND DELIVERS ON FIVE PILLARS OF VALUE-CREATING DIFFERENTIATION 1. Dedicated Focus Next generation Precision Diagnostics, where we have deep domain competence and market tailwinds 2. Investor Friendly We openly share investment analyses and preserve an opt-out option for our investors 3. Global Influence We have proprietary connections to global companies, markets, and trend-setting projects 4. Engaged Diligence We are not passive investors, starting with an operational engagement even before we invest 5. Transformational Companies We can afford to be patient and will invest only in companies we believe can have a disruptive impact and the potential for...

READ MORE
Our Approach Intro

Our Approach and Why it Matters

READ MORE
GreyBird Ventures

is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.

MEET THE PEOPLE

For additional information, please contact: greybird@greybirdventures.com

DISCLAIMER